Connect with us

Nomura: What’s Behind The Market’s “Monster” Upward Flows And How It Could All Go Horribly Wrong

Today’s market action, despite a modest spike in Eminis after the big retail sales miss and the even more unexpected jump in yields…

Published

on

Nomura: What's Behind The Market's "Monster" Upward Flows And How It Could All Go Horribly Wrong
Today's market action, despite a modest spike in Eminis after the big retail sales miss and the even more unexpected jump in yields despite the latest confirmation the US economy is slowing down rapidly, generally makes sense at least in the context of the absolutely bizarre market action in recent weeks: Chinese Equities are struggling to digest the ugly weekend data misses coupled with the latest now-daily crackdown and warning from SEC head Gensler, while in the US, stocks are drifting on fresh lockdown fears (after New Zealand locked down its entire economy after 1 (ONE) case of covid) and fears the best is far behind us in an economy where retail sales have missed for the past three months while the Citi Global Economic Surprise Index is lunging back towards “zero” after 14 consecutive months of “upside surprises” from the economic recovery. But - as Nomura's Charlie McElligott writes in his morning note, - "how about yesterday’s S&P 44-handle rip off the lows?! " Rehashing what we wrote last June in our primer on gamma and option-driven equity flows, where we quoted Goldman who said that "Gamma has the potential to be one of the most important non-fundamental flows in equity markets (particularly when "short gamma" causes volatility to accelerate)", McElligott writes that in standard “tail wags the dog” fashion, "two monster options-derived / vol-sensitive flows simply overwhelmed all macroeconomic- and geopolitical- narratives on the day" and continues:
Options Dealers are choking on prolific long ATM Gamma into Op-Ex (SPX and SPY consolidated $Gamma at $39.3B, 94%ile), which simply means that selloffs would be bot and ripped back - crushing the daily distribution of outcomes into a narrow band for effectively an entire month now and smashing realized volatility. This goes part-and-parcel with enormous Vol Control universe buying as we told you expect Thursday, adding prolific amounts exposure off the back of the absolute collapse in trailing realized volatility; as of this morning, we see SPX 5d rVol = 0.9 (which was last seen in Sep and Oct of 2017), while 1m rVol printed 8.3 / 3.5%ile rank…and 3m realized registered 9.2 vols, a stunning 0.4%ile
While we have discussed the nuances of gamma's impact on markets, most recently yesterday when we addressed the possibility of a VIX acceleration, we give the podium to the Nomura cross-asset strategist who unpacks the equities options positioning component of the power move higher off the nervous morning lows made yesterday, "especially as hedger sensitivities are inherently growing into tomorrow’s VIXpiration and Friday’s Op-Ex which should act as the peak of this week’s melt-up." Here is his explanation:
Currently, markets are absolutely stuck and pinning btwn the large ATM $Gamma strikes ($5.5B at 4450 and $5.7B at 4475, with $12.3B acting as potential gravity for a move up to 4500, which is now the largest strike by a factor of 2x), as Dealer Gamma profile vs spot location means pure insulation / mean-reversion hedging flows As our analysis projects as of this morning, we expect a lumpy / outsized ~36% of SPX / SPY consolidated options Gamma to drop after Friday’s monthly expiry, with $Delta of course growing into expiration and in nosebleed territory at $407.8B (95%ile)—meaning this could act as an enormous unwind flow on a pullback when / if those hedging buffers are reduced in that magnitude, allowing the market to “move” thereafter as volatility could then again expand. QQQ (Nasdaq) options positioning is even more extreme, with 99%ile $Gamma and 94%-ile $Delta, with an eye-watering 53% of that $Gamma rolling-off Friday…just a massive potential “un-pinning” thereafter, but “stuck” for now But with the “Gamma Hammer” spraying the Street with LOADS of $Gamma twice a day and ~ 3 times a week (via their “strangle selling”) — while overwriters too pile-on in standard index and single-name option selling programs — the inability for the market to move more than 20 to 50bps a day is totally unsurprising, while being simultaneously excruciating for anybody bleeding Theta
Gamma aside, there is also the Vol Control component (forced buying or selling around given vol lookback levels) of yesterday’s rally, which occurred on account of trailing realized volatility windows making new lows in large part thanks to this aforementioned “peak long Gamma” placing the market in a chokehold, which in-turn mechanically elicits what has been extremely “outlier” exposure adding in recent days / weeks / months, and has now taken the overall dollar allocation to Equities in Nomura's Vol Control model to 87%ile over the past 10 years relative. Here are the staggering forced buying numbers per Charlie:  1d Vol Control exposure change = +$35.6B, 99.5%ile; 2d change = +$46.1B, 99.3%; 1w change = +$49.7B, 98.2%ile; 2w change = +$ 60.8B, 97.1%ile; 3m change = +$107.1B, 91.4%ile; 6m change = +$118.5B, 91.9%ile And there you have it: according to McElligott, the recent action has been "just massive “buy” flows into that itsy-bitsy pullback Monday morning and taking-us right back in the peak “long gamma = rVol pinning” strikezone, feeding our anticipated “melt-up into Op-Ex” call." But, as he further adds, "outside of this decimated index-level realized volatility in isolation, many volatility metrics continue screaming YIKES!, which is why we have continued to see super “nervy” jumps in VIX space on utterly negligible moves lower in spot index in recent months." One such metric is the Skew which we have discussed frequently in the past touching on the various drivers of all the demand for skew…not just longer-date “crash” downside hedges, but really about a mismatch on tenor and general Vol supply-and-demand. Here is an updated SKEW list from McElligott:
  • Huge notional Equities books to hedge with markets at all-time highs, rallying in violent and uncomfortable fashion (SPX closing yday +100.2% off the 3/23/20 COVID19 pandemic low)
  • Fed “taper tantrum” concerns, as emergency liquidity accommodation is set to be unwound, as the recovery continues to power-on
  • Inflation regime change risk impact of “bonds as your hedge” correlation, in-turn driving new user demand for Equities Vol as a hedge
  • But most critically, this is simply about complete and utter imbalance in the enormous demand for term-volatility, versus little-to-no supply of volatility that is not short-dated and/or at-the-money without daisy-chaining into more pricing extremes, which is largely a function of Dealer regulatory risk management implications (too many VaR events in recent history, which require desks to try and stay “crash positive” in stress slides)…and why, according to Nomura, "all these vol metrics are so out-of-wack!"
Said another way, Dealers can’t be short skew / crash / tails / gamma without causing knock-on into even more extreme vol metrics as they need to hedge themselves likely via liquidity from other risk-constrained Dealers and a downsized market-maker liquidity profile. Meanwhile, vol metrics remain super-tense, tightly-wound and pricing “crash,” juxtaposed to realized vol grinding ever-lower—which simply means one side will have to converge to the other in likely precipitous fashion as this “trues-up” eventually - translating either into an epic risk meltup or... meltdown.
  • SPX 1m iVol / rVol 91.5%ile, 3m iVol / rVol 93.5%ile
  • QQQ 1m iVol / rVol 96.4%ile, 3m iVol / rVol 99.4%ile
  • SPX 1m Skew 97.8%ile
  • QQQ 1m Skew 94.0%ile
  • SPX 1m downside Put Skew 99.0%ile
  • QQQ 1m downside Put Skew 95.7%ile
  • VIX 2w Call Skew 99%ile, 2m 100%ile, 3m 100%ile, 6m 100%ile
  • SPX 3m / 1m Term Structure 97.6%ile
  • QQQ 3m / 1m Term Structure 97.0%ile
  • VVIX / VIX ratio +2SD (1Y relative)
This is where it gets even more complicated, because with realized volatility this low on absolute levels, and with systematic exposures this high (the CTA Trend model also sitting at 86%ile gross exposure over the past 10Y), this is how a seemingly “small” move in market could feed into a larger move in Vol which could see a totally outsized “CRASH” selloff occur thereafter—particularly in the case of the Op-Ex cycle “turn” timing, as we earlier stated a significant amount of “Gamma unclench” this expiration. As such, this extended loading of systematic exposure on the realized vol compression is most likely the single largest “risk” in this market, because whatever the “spark” that lights the flame of movement, there is simply an enormous amount of mechanical derisking to occur, especially if we were to push “spot” down to a point where options Dealers are then piling-onto de-grossing flows via their “short Gamma” accelerant flows, i.e., selling leading to much more selling. Indeed, as shown in the SPX options charts, “Gamma vs spot” would flip below 4306 this week / 4301 ex this expiration, with peak “short Gamma” around 4180. So as McElligott summarizes, the post Op-Ex cycle turn "is the window where any semblance of pullback would then need to align with these big “delta one” type flows being hyper-susceptible to a de-grossing event, all thanks to this extended positioning against extraordinarily low realized volatility—low probability it can all occur, but definitely the way a -1.5% move could turn into a -3% or -5% too."
  • A market super-long $Delta as potential flow “out”--check
  • Prolific systematic “vol sensitive” fund exposure as potential flow “out”—check
  • Relaxation of the current “long Gamma” market insulation which chokes-out movement—seemingly in position to occur after Friday morning’s expiration (See below strikes for SPX options gamma dropoff, particularly ATM kind)
One final point for those wondering how bad the ensuing deleveraging could be, the Nomura quant writes that with all this "outlier long" systematic exposure vs “historically low” realized vol, here are his forward $ estimates of exposure reduction supply which could hypothetically occur on even just a smallish “down day” (-1.5% to -2.0%), Friday through next week in the Vol Control model.
Tyler Durden Tue, 08/17/2021 - 11:39

Read More

Continue Reading

Government

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

Authored by Jack Phillips via The Epoch Times (emphasis ours),

A…

Published

on

CDC Warns Thousands Of Children Sent To ER After Taking Common Sleep Aid

Authored by Jack Phillips via The Epoch Times (emphasis ours),

A U.S. Centers for Disease Control (CDC) paper released Thursday found that thousands of young children have been taken to the emergency room over the past several years after taking the very common sleep-aid supplement melatonin.

The Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia, on April 23, 2020. (Tami Chappell/AFP via Getty Images)

The agency said that melatonin, which can come in gummies that are meant for adults, was implicated in about 7 percent of all emergency room visits for young children and infants “for unsupervised medication ingestions,” adding that many incidents were linked to the ingestion of gummy formulations that were flavored. Those incidents occurred between the years 2019 and 2022.

Melatonin is a hormone produced by the human body to regulate its sleep cycle. Supplements, which are sold in a number of different formulas, are generally taken before falling asleep and are popular among people suffering from insomnia, jet lag, chronic pain, or other problems.

The supplement isn’t regulated by the U.S. Food and Drug Administration and does not require child-resistant packaging. However, a number of supplement companies include caps or lids that are difficult for children to open.

The CDC report said that a significant number of melatonin-ingestion cases among young children were due to the children opening bottles that had not been properly closed or were within their reach. Thursday’s report, the agency said, “highlights the importance of educating parents and other caregivers about keeping all medications and supplements (including gummies) out of children’s reach and sight,” including melatonin.

The approximately 11,000 emergency department visits for unsupervised melatonin ingestions by infants and young children during 2019–2022 highlight the importance of educating parents and other caregivers about keeping all medications and supplements (including gummies) out of children’s reach and sight.

The CDC notes that melatonin use among Americans has increased five-fold over the past 25 years or so. That has coincided with a 530 percent increase in poison center calls for melatonin exposures to children between 2012 and 2021, it said, as well as a 420 percent increase in emergency visits for unsupervised melatonin ingestion by young children or infants between 2009 and 2020.

Some health officials advise that children under the age of 3 should avoid taking melatonin unless a doctor says otherwise. Side effects include drowsiness, headaches, agitation, dizziness, and bed wetting.

Other symptoms of too much melatonin include nausea, diarrhea, joint pain, anxiety, and irritability. The supplement can also impact blood pressure.

However, there is no established threshold for a melatonin overdose, officials have said. Most adult melatonin supplements contain a maximum of 10 milligrams of melatonin per serving, and some contain less.

Many people can tolerate even relatively large doses of melatonin without significant harm, officials say. But there is no antidote for an overdose. In cases of a child accidentally ingesting melatonin, doctors often ask a reliable adult to monitor them at home.

Dr. Cora Collette Breuner, with the Seattle Children’s Hospital at the University of Washington, told CNN that parents should speak with a doctor before giving their children the supplement.

“I also tell families, this is not something your child should take forever. Nobody knows what the long-term effects of taking this is on your child’s growth and development,” she told the outlet. “Taking away blue-light-emitting smartphones, tablets, laptops, and television at least two hours before bed will keep melatonin production humming along, as will reading or listening to bedtime stories in a softly lit room, taking a warm bath, or doing light stretches.”

In 2022, researchers found that in 2021, U.S. poison control centers received more than 52,000 calls about children consuming worrisome amounts of the dietary supplement. That’s a six-fold increase from about a decade earlier. Most such calls are about young children who accidentally got into bottles of melatonin, some of which come in the form of gummies for kids, the report said.

Dr. Karima Lelak, an emergency physician at Children’s Hospital of Michigan and the lead author of the study published in 2022 by the CDC, found that in about 83 percent of those calls, the children did not show any symptoms.

However, other children had vomiting, altered breathing, or other symptoms. Over the 10 years studied, more than 4,000 children were hospitalized, five were put on machines to help them breathe, and two children under the age of two died. Most of the hospitalized children were teenagers, and many of those ingestions were thought to be suicide attempts.

Those researchers also suggested that COVID-19 lockdowns and virtual learning forced more children to be at home all day, meaning there were more opportunities for kids to access melatonin. Also, those restrictions may have caused sleep-disrupting stress and anxiety, leading more families to consider melatonin, they suggested.

The Associated Press contributed to this report.

Tyler Durden Mon, 03/11/2024 - 21:40

Read More

Continue Reading

International

Red Candle In The Wind

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by…

Published

on

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by printing at 275,000 against a consensus call of 200,000. We say superficially, because the downward revisions to prior months totalled 167,000 for December and January, taking the total change in employed persons well below the implied forecast, and helping the unemployment rate to pop two-ticks to 3.9%. The U6 underemployment rate also rose from 7.2% to 7.3%, while average hourly earnings growth fell to 0.2% m-o-m and average weekly hours worked languished at 34.3, equalling pre-pandemic lows.

Undeterred by the devil in the detail, the algos sprang into action once exchanges opened. Market darling NVIDIA hit a new intraday high of $974 before (presumably) the humans took over and sold the stock down more than 10% to close at $875.28. If our suspicions are correct that it was the AIs buying before the humans started selling (no doubt triggering trailing stops on the way down), the irony is not lost on us.

The 1-day chart for NVIDIA now makes for interesting viewing, because the red candle posted on Friday presents quite a strong bearish engulfing signal. Volume traded on the day was almost double the 15-day simple moving average, and similar price action is observable on the 1-day charts for both Intel and AMD. Regular readers will be aware that we have expressed incredulity in the past about the durability the AI thematic melt-up, so it will be interesting to see whether Friday’s sell off is just a profit-taking blip, or a genuine trend reversal.

AI equities aside, this week ought to be important for markets because the BTFP program expires today. That means that the Fed will no longer be loaning cash to the banking system in exchange for collateral pledged at-par. The KBW Regional Banking index has so far taken this in its stride and is trading 30% above the lows established during the mini banking crisis of this time last year, but the Fed’s liquidity facility was effectively an exercise in can-kicking that makes regional banks a sector of the market worth paying attention to in the weeks ahead. Even here in Sydney, regulators are warning of external risks posed to the banking sector from scheduled refinancing of commercial real estate loans following sharp falls in valuations.

Markets are sending signals in other sectors, too. Gold closed at a new record-high of $2178/oz on Friday after trading above $2200/oz briefly. Gold has been going ballistic since the Friday before last, posting gains even on days where 2-year Treasury yields have risen. Gold bugs are buying as real yields fall from the October highs and inflation breakevens creep higher. This is particularly interesting as gold ETFs have been recording net outflows; suggesting that price gains aren’t being driven by a retail pile-in. Are gold buyers now betting on a stagflationary outcome where the Fed cuts without inflation being anchored at the 2% target? The price action around the US CPI release tomorrow ought to be illuminating.

Leaving the day-to-day movements to one side, we are also seeing further signs of structural change at the macro level. The UK budget last week included a provision for the creation of a British ISA. That is, an Individual Savings Account that provides tax breaks to savers who invest their money in the stock of British companies. This follows moves last year to encourage pension funds to head up the risk curve by allocating 5% of their capital to unlisted investments.

As a Hail Mary option for a government cruising toward an electoral drubbing it’s a curious choice, but it’s worth highlighting as cash-strapped governments increasingly see private savings pools as a funding solution for their spending priorities.

Of course, the UK is not alone in making creeping moves towards financial repression. In contrast to announcements today of increased trade liberalisation, Australian Treasurer Jim Chalmers has in the recent past flagged his interest in tapping private pension savings to fund state spending priorities, including defence, public housing and renewable energy projects. Both the UK and Australia appear intent on finding ways to open up the lungs of their economies, but government wants more say in directing private capital flows for state goals.

So, how far is the blurring of the lines between free markets and state planning likely to go? Given the immense and varied budgetary (and security) pressures that governments are facing, could we see a re-up of WWII-era Victory bonds, where private investors are encouraged to do their patriotic duty by directly financing government at negative real rates?

That would really light a fire under the gold market.

Tyler Durden Mon, 03/11/2024 - 19:00

Read More

Continue Reading

Government

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19…

Published

on

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19 vaccination was a mistake due to ethical and other concerns, a top government doctor warned Dr. Anthony Fauci after Dr. Fauci promoted mass vaccination.

Coercing or forcing people to take a vaccine can have negative consequences from a biological, sociological, psychological, economical, and ethical standpoint and is not worth the cost even if the vaccine is 100% safe,” Dr. Matthew Memoli, director of the Laboratory of Infectious Diseases clinical studies unit at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), told Dr. Fauci in an email.

“A more prudent approach that considers these issues would be to focus our efforts on those at high risk of severe disease and death, such as the elderly and obese, and do not push vaccination on the young and healthy any further.”

Dr. Anthony Fauci, ex-director of the National Institute of Allergy and Infectious Diseases (NIAID. in Washington on Jan. 8, 2024. (Madalina Vasiliu/The Epoch Times)

Employing that strategy would help prevent loss of public trust and political capital, Dr. Memoli said.

The email was sent on July 30, 2021, after Dr. Fauci, director of the NIAID, claimed that communities would be safer if more people received one of the COVID-19 vaccines and that mass vaccination would lead to the end of the COVID-19 pandemic.

“We’re on a really good track now to really crush this outbreak, and the more people we get vaccinated, the more assuredness that we’re going to have that we’re going to be able to do that,” Dr. Fauci said on CNN the month prior.

Dr. Memoli, who has studied influenza vaccination for years, disagreed, telling Dr. Fauci that research in the field has indicated yearly shots sometimes drive the evolution of influenza.

Vaccinating people who have not been infected with COVID-19, he said, could potentially impact the evolution of the virus that causes COVID-19 in unexpected ways.

“At best what we are doing with mandated mass vaccination does nothing and the variants emerge evading immunity anyway as they would have without the vaccine,” Dr. Memoli wrote. “At worst it drives evolution of the virus in a way that is different from nature and possibly detrimental, prolonging the pandemic or causing more morbidity and mortality than it should.”

The vaccination strategy was flawed because it relied on a single antigen, introducing immunity that only lasted for a certain period of time, Dr. Memoli said. When the immunity weakened, the virus was given an opportunity to evolve.

Some other experts, including virologist Geert Vanden Bossche, have offered similar views. Others in the scientific community, such as U.S. Centers for Disease Control and Prevention scientists, say vaccination prevents virus evolution, though the agency has acknowledged it doesn’t have records supporting its position.

Other Messages

Dr. Memoli sent the email to Dr. Fauci and two other top NIAID officials, Drs. Hugh Auchincloss and Clifford Lane. The message was first reported by the Wall Street Journal, though the publication did not publish the message. The Epoch Times obtained the email and 199 other pages of Dr. Memoli’s emails through a Freedom of Information Act request. There were no indications that Dr. Fauci ever responded to Dr. Memoli.

Later in 2021, the NIAID’s parent agency, the U.S. National Institutes of Health (NIH), and all other federal government agencies began requiring COVID-19 vaccination, under direction from President Joe Biden.

In other messages, Dr. Memoli said the mandates were unethical and that he was hopeful legal cases brought against the mandates would ultimately let people “make their own healthcare decisions.”

“I am certainly doing everything in my power to influence that,” he wrote on Nov. 2, 2021, to an unknown recipient. Dr. Memoli also disclosed that both he and his wife had applied for exemptions from the mandates imposed by the NIH and his wife’s employer. While her request had been granted, his had not as of yet, Dr. Memoli said. It’s not clear if it ever was.

According to Dr. Memoli, officials had not gone over the bioethics of the mandates. He wrote to the NIH’s Department of Bioethics, pointing out that the protection from the vaccines waned over time, that the shots can cause serious health issues such as myocarditis, or heart inflammation, and that vaccinated people were just as likely to spread COVID-19 as unvaccinated people.

He cited multiple studies in his emails, including one that found a resurgence of COVID-19 cases in a California health care system despite a high rate of vaccination and another that showed transmission rates were similar among the vaccinated and unvaccinated.

Dr. Memoli said he was “particularly interested in the bioethics of a mandate when the vaccine doesn’t have the ability to stop spread of the disease, which is the purpose of the mandate.”

The message led to Dr. Memoli speaking during an NIH event in December 2021, several weeks after he went public with his concerns about mandating vaccines.

“Vaccine mandates should be rare and considered only with a strong justification,” Dr. Memoli said in the debate. He suggested that the justification was not there for COVID-19 vaccines, given their fleeting effectiveness.

Julie Ledgerwood, another NIAID official who also spoke at the event, said that the vaccines were highly effective and that the side effects that had been detected were not significant. She did acknowledge that vaccinated people needed boosters after a period of time.

The NIH, and many other government agencies, removed their mandates in 2023 with the end of the COVID-19 public health emergency.

A request for comment from Dr. Fauci was not returned. Dr. Memoli told The Epoch Times in an email he was “happy to answer any questions you have” but that he needed clearance from the NIAID’s media office. That office then refused to give clearance.

Dr. Jay Bhattacharya, a professor of health policy at Stanford University, said that Dr. Memoli showed bravery when he warned Dr. Fauci against mandates.

“Those mandates have done more to demolish public trust in public health than any single action by public health officials in my professional career, including diminishing public trust in all vaccines.” Dr. Bhattacharya, a frequent critic of the U.S. response to COVID-19, told The Epoch Times via email. “It was risky for Dr. Memoli to speak publicly since he works at the NIH, and the culture of the NIH punishes those who cross powerful scientific bureaucrats like Dr. Fauci or his former boss, Dr. Francis Collins.”

Tyler Durden Mon, 03/11/2024 - 17:40

Read More

Continue Reading

Trending